1-2 of 2
Keywords: Docosahexaenoic acid
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder

Free
Subject Area:
Topic Article Package: Moksha , Psychiatry and Psychology
Ta-Wei Guu, David Mischoulon, Jerome Sarris, Joseph Hibbeln, Robert K. McNamara, Kei Hamazaki, Marlene P. Freeman, Michael Maes, Yutaka J. Matsuoka, R.H. Belmaker, Felice Jacka, Carmine Pariante, Michael Berk, Wolfgang Marx, Kuan-Pin Su
Journal: Psychotherapy and Psychosomatics
Psychother Psychosom (2019) 88 (5): 263–273.
https://doi.org/10.1159/000502652
Published Online: 03 September 2019
... and dosage, both pure eicosapentaenoic acid (EPA) or an EPA/docosahexaenoic acid (DHA) combination of a ratio higher than 2 (EPA/DHA >2) are considered effective, and the recommended dosages should be 1–2 g of net EPA daily, from either pure EPA or an EPA/DHA (>2:1) formula; (3) the quality of n–3...
View articletitled, International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder
Open the PDF for International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder in another window
Journal Articles

Clinical Efficacy and Biological Regulations of ω–3 PUFA-Derived Endocannabinoids in Major Depressive Disorder

Available to Purchase
Subject Area:
Topic Article Package: Moksha , Psychiatry and Psychology
Bo Yang, Lin Lin, Richard P. Bazinet, Yu-Chuan Chien, Jane Pei-Chen Chang, Senthil Kumaran Satyanarayanan, Huanxing Su, Kuan-Pin Su
Journal: Psychotherapy and Psychosomatics
Psychother Psychosom (2019) 88 (4): 215–224.
https://doi.org/10.1159/000501158
Published Online: 03 July 2019
... randomly assigned to receive eicosapentaenoic acid (EPA, 3.0 g/day), docosahexaenoic acid (DHA, 1.4 g/day), or a combination of EPA (1.5 g/d) and DHA (0.7 g/day). Eighty-five participants completed the trial, and their clinical remission and plasma PUFA-derived EC levels (pmol/mL) were measured. Results...
View articletitled, Clinical Efficacy and Biological Regulations of ω–3 PUFA-Derived Endocannabinoids in Major Depressive Disorder
Open the PDF for Clinical Efficacy and Biological Regulations of ω–3 PUFA-Derived Endocannabinoids in Major Depressive Disorder in another window